SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-063929
Filing Date
2020-12-16
Accepted
2020-12-16 20:55:58
Documents
1
Period of Report
2020-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3632
  Complete submission text file 0001209191-20-063929.txt   5176
Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
ASELAGE STEVE (Reporting) CIK: 0001221599 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 201394003

Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations